Your browser doesn't support javascript.
loading
Innate immune receptor signaling induces transient melanoma dedifferentiation while preserving immunogenicity.
Thier, Beatrice; Zhao, Fang; Stupia, Simone; Brüggemann, Alicia; Koch, Johannes; Schulze, Nina; Horn, Susanne; Coch, Christoph; Hartmann, Gunther; Sucker, Antje; Schadendorf, Dirk; Paschen, Annette.
Afiliación
  • Thier B; Department of Dermatology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
  • Zhao F; German Cancer Consortium (DKTK), Partner Site Essen/Düsseldorf, Essen, Germany.
  • Stupia S; Department of Dermatology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
  • Brüggemann A; German Cancer Consortium (DKTK), Partner Site Essen/Düsseldorf, Essen, Germany.
  • Koch J; Department of Dermatology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
  • Schulze N; German Cancer Consortium (DKTK), Partner Site Essen/Düsseldorf, Essen, Germany.
  • Horn S; Department of Dermatology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
  • Coch C; German Cancer Consortium (DKTK), Partner Site Essen/Düsseldorf, Essen, Germany.
  • Hartmann G; Imaging Center Campus Essen, Center of Medical Biotechnology (ZMB), University of Duisburg-Essen, Essen, Germany.
  • Sucker A; Imaging Center Campus Essen, Center of Medical Biotechnology (ZMB), University of Duisburg-Essen, Essen, Germany.
  • Schadendorf D; Rudolf Schönheimer Institute of Biochemistry, University of Leipzig, Leipzig, Germany.
  • Paschen A; Institute of Clinical Chemistry and Clinical Pharmacology, University of Bonn, Bonn, Germany.
J Immunother Cancer ; 10(6)2022 06.
Article en En | MEDLINE | ID: mdl-35697379

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Melanoma Tipo de estudio: Prognostic_studies Idioma: En Revista: J Immunother Cancer Año: 2022 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Melanoma Tipo de estudio: Prognostic_studies Idioma: En Revista: J Immunother Cancer Año: 2022 Tipo del documento: Article